BSF Enterprise Plc

LSE • Healthcare • Biotechnology • Quote as of 10/30/2026

Company Profile

IndustryBiotechnology

SectorHealthcare

ExchangeLSE

Market Capitalization1.83 mln

Float201 mln

Earnings Date02/04/2027

Piotroski F-Score

3 / 9

Below average

Beneish M-Score

-1.72

Likely manipulated

Relative Strength

13 / 100

Significantly lagging

Debt / Equity

0.27

Very low leverage

Pre-Tax Margin

-2,829%

Severely loss-making

ROE

-52.09

Deeply negative

Business Description

Founded in 2018 and headquartered in London, BSF Enterprise Plc is a UK and Hong Kong-based company that grows living tissues in laboratory settings for medical and commercial use. The company focuses on developing artificial corneas, lab-grown meat, and advanced skin treatments, while also building a portfolio of biotechnology and e-commerce businesses.

Key Fundamentals

EPS-1.00

ROE-52.09

RPS0.00

ROIC-53.65

ROA-39.70

Interest Cover-160

EBITDA, mln-1.33

EV / EBITDA-1.96

EV / EBIT-1.82

Revenue, mln0.05

EV / Revenue51.22

Quote Details

Last 0.94

Change 0.0835 (9.75%)

Open 0.95

Volume 1,570,697

Turnover 1,476,455

Average Volume 1,514,537

Financial Ratios

Pre-Tax Profit Margin-2,829

Leverage Ratio1.97

Current Ratio0.33

Price / Book0.68

Debt / Equity0.27

Price / Sales0.23

Financial Strength

Altman Z-Score0.85

Piotroski F-Score 3 / 9

Beneish M-Score-1.72

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	3.18%	90 / 100
1 Month	-18.26%	5 / 100
2 Months	4.44%	80 / 100
6 Months	-53%	2 / 100
1 Year	-69.58%	2 / 100